Gregg Schmedes, MD
Otolaryngology · Albuquerque, NMNPI 1386872497
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Pfizer at 40.9% of the total. Reporting peaked in 2024 at $608 and has fallen 74.1% since, to $158 in 2025.
Across 36 payments — averaging $33.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$500
- GSK$231
- Regeneron Healthcare Solutions, Inc.$126
- Aerin Medical Inc.$84
- Sanofi$77
- Inspire Medical Systems, Inc.$60
- plus $144 from 5 others
What the payments were for
- Speaking & faculty fees$50041%
- Food & beverage$72259%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $500 |
| GSK | 12 | $231 |
| Regeneron Healthcare Solutions, Inc. | 5 | $126 |
| Aerin Medical Inc. | 4 | $84 |
| Sanofi | 3 | $77 |
| Inspire Medical Systems, Inc. | 2 | $60 |
| Optinose US, Inc. | 3 | $39 |
| Stryker | 2 | $38 |
| Merck | 2 | $29 |
| Smith+Nephew | 1 | $21 |
| Novartis | 1 | $17 |
How this compares
$1,222 in reported general payments places this provider in the 75th percentile of 39 otolaryngology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 32 | $720 |
| Azelastine Hcl | 17 | $312 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Albuquerque
- Jason MuddAlbuquerque$9K
- Ryan OroscoAlbuquerque$8K
- Shervin AminpourAlbuquerque$5K
- Lily LoveAlbuquerque$3K
- Noah SymeAlbuquerque$2K
- Robert MartinAlbuquerque$2K
- Garth OlsonAlbuquerque$1K
- Angela MartinAlbuquerque$328
- Tania KraaiAlbuquerque$318
- Bonnie RenfroAlbuquerque$274
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.